Neither LKB1 nor AMPK are the direct targets of metformin

Gastroenterology. 2006 Sep;131(3):973; author reply 974-5. doi: 10.1053/j.gastro.2006.07.032.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • AMP-Activated Protein Kinases
  • Animals
  • Diabetes Mellitus / enzymology
  • Diabetes Mellitus / prevention & control
  • Hypoglycemic Agents / pharmacology*
  • In Vitro Techniques
  • Metformin / pharmacology*
  • Mice
  • Multienzyme Complexes / drug effects
  • Multienzyme Complexes / metabolism*
  • Protein-Serine-Threonine Kinases / drug effects
  • Protein-Serine-Threonine Kinases / metabolism*
  • Rats

Substances

  • Hypoglycemic Agents
  • Multienzyme Complexes
  • Metformin
  • Protein-Serine-Threonine Kinases
  • AMP-Activated Protein Kinases